Li Ning Company Limited announced the grant of 12.61 million share options under its 2024 Share Option Scheme, representing approximately 0.49% of the company’s issued share capital both on the grant date and on the scheme’s adoption date.
The options, awarded on 27 August 2026, carry an exercise price of HK$13.90 per share—the higher of (1) the HK$13.68 closing price on the grant date, (2) the five-day average closing price of HK$13.90, and (3) the HK$0.10 nominal value. Subject to vesting conditions, the options are exercisable until 31 December 2034.
Vesting is time-based and split evenly across three tranches: • 1 September 2027: 33.3% • 1 September 2028: 33.3% • 1 September 2029: 33.3%
Of the total grant, 2.02 million options went to Executive Directors Kosaka Takeshi and Li Qilin (1.01 million each), equal to 0.04% of issued shares apiece. The remaining 10.59 million options were allocated to eight full-time employees. All director grants were approved by the company’s independent non-executive directors in line with Hong Kong Listing Rule 17.04(1).
The share options include built-in lapse and cancellation provisions but no additional claw-back mechanism or preset performance targets. After this issuance, 105.60 million shares remain available for future grants under the scheme mandate. No financial assistance will be provided to option holders for share purchases.
Comments